Compare Procter & Gamble Health with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs SANOFI INDIA - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH SANOFI INDIA PROCTER & GAMBLE HEALTH/
SANOFI INDIA
 
P/E (TTM) x 52.7 36.1 145.7% View Chart
P/BV x 4.8 6.3 75.3% View Chart
Dividend Yield % 10.0 1.4 722.6%  

Financials

 PROCTER & GAMBLE HEALTH   SANOFI INDIA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
SANOFI INDIA
Dec-18
PROCTER & GAMBLE HEALTH/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3,5496,840 51.9%   
Low Rs1,3014,630 28.1%   
Sales per share (Unadj.) Rs511.41,203.1 42.5%  
Earnings per share (Unadj.) Rs61.3165.3 37.1%  
Cash flow per share (Unadj.) Rs74.0209.9 35.3%  
Dividends per share (Unadj.) Rs440.0084.00 523.8%  
Dividend yield (eoy) %18.11.5 1,238.7%  
Book value per share (Unadj.) Rs927.8963.6 96.3%  
Shares outstanding (eoy) m16.6023.03 72.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.74.8 99.5%   
Avg P/E ratio x39.634.7 114.0%  
P/CF ratio (eoy) x32.827.3 119.9%  
Price / Book Value ratio x2.66.0 43.9%  
Dividend payout %717.950.8 1,412.4%   
Avg Mkt Cap Rs m40,257132,078 30.5%   
No. of employees `0001.13.3 34.4%   
Total wages/salary Rs m1,3134,068 32.3%   
Avg. sales/employee Rs Th7,486.78,393.8 89.2%   
Avg. wages/employee Rs Th1,157.61,232.4 93.9%   
Avg. net profit/employee Rs Th897.21,153.0 77.8%   
INCOME DATA
Net Sales Rs m8,49027,708 30.6%  
Other income Rs m244897 27.2%   
Total revenues Rs m8,73428,605 30.5%   
Gross profit Rs m1,4826,235 23.8%  
Depreciation Rs m2111,027 20.6%   
Interest Rs m07 0.0%   
Profit before tax Rs m1,5146,098 24.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m5632,292 24.5%   
Profit after tax Rs m1,0173,806 26.7%  
Gross profit margin %17.522.5 77.6%  
Effective tax rate %37.137.6 98.8%   
Net profit margin %12.013.7 87.2%  
BALANCE SHEET DATA
Current assets Rs m15,34315,922 96.4%   
Current liabilities Rs m1,9606,235 31.4%   
Net working cap to sales %157.635.0 450.9%  
Current ratio x7.82.6 306.5%  
Inventory Days Days4964 76.6%  
Debtors Days Days2821 136.3%  
Net fixed assets Rs m1,2097,539 16.0%   
Share capital Rs m166230 72.2%   
"Free" reserves Rs m15,23521,962 69.4%   
Net worth Rs m15,40122,192 69.4%   
Long term debt Rs m00-   
Total assets Rs m17,59529,839 59.0%  
Interest coverage xNM872.1-  
Debt to equity ratio x00-  
Sales to assets ratio x0.50.9 52.0%   
Return on assets %5.812.8 45.3%  
Return on equity %6.617.2 38.5%  
Return on capital %10.327.5 37.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,6367,587 21.6%   
Fx outflow Rs m4,3687,145 61.1%   
Net fx Rs m-2,732442 -618.1%   
CASH FLOW
From Operations Rs m-1,3043,739 -34.9%  
From Investments Rs m12,697-731 -1,737.0%  
From Financial Activity Rs m-301-1,972 15.2%  
Net Cashflow Rs m11,0931,036 1,070.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 60.4 85.8%  
Indian inst/Mut Fund % 18.2 14.4 126.4%  
FIIs % 1.0 14.6 6.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 10.5 277.1%  
Shareholders   28,591 15,184 188.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   J.B.CHEMICALS  ALEMBIC LTD  CIPLA  CADILA HEALTHCARE  SUVEN LIFESCIENCES  

Compare PROCTER & GAMBLE HEALTH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Oct 18, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS